載入...
Are calcineurin inhibitors safer than mTOR inhibitors?
Isakova et al. report that kidney transplant recipients on mammalian target of rapamycin (mTOR) inhibitors do not have a lower risk of allograft failure but do have a higher risk of death than those on calcineurin inhibitors. Careful consideration is, therefore, required before converting to mTOR in...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3951270/ https://ncbi.nlm.nih.gov/pubmed/23183834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneph.2012.262 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|